CLEVELAND, Ohio – Akesis, Inc. (Akesis), a leader in cutting-edge radiation oncology technology, has formed a groundbreaking collaboration with University Hospitals Seidman Cancer Center, a nationally recognized cancer care institution. Through this alliance, UH Seidman Cancer Center becomes the first medical center in the United States to implement the innovative Akesis Galaxy RTi device for patient treatments, while also serving as the flagship site for research and clinical demonstration of this advanced technology.
As part of the agreement, UH Seidman Cancer Center will incorporate the Galaxy RTi into the stereotactic radiosurgery (SRS) program, aiming to set new benchmarks in precision treatment and patient outcomes. The center will also provide healthcare professionals worldwide with the opportunity to engage directly with the system’s capabilities through on-site demonstrations and research initiatives.
"We are thrilled to reach this significant milestone with University Hospitals Seidman Cancer Center," said Lien Pham, VP and COO of Akesis. "The Galaxy RTi represents a major leap forward in SRS technology, and we believe this collaboration will maximize its impact, benefiting patients worldwide."
Dr. Daniel Spratt, Chair of Radiation Oncology at UH Seidman Cancer Center in Cleveland, Associate Chief Scientific Officer of University Hospitals Cleveland Medical Center and Vincent K. Smith Chair in Radiation Oncology, expressed his excitement about the collaboration, stating, "At UH Seidman Cancer Center, we are committed to leading the adoption of breakthrough technologies that advance patient care. This collaboration with Akesis underscores our mission to transform cancer treatment and establish new standards in the field."
This initiative is set to accelerate the integration of next-generation radiation technologies, foster a culture of innovation, and elevate the standard of care. Together, Akesis and UH Seidman Cancer Center aim to improve patient outcomes, enhance treatment efficiency, and contribute to the evolution of global cancer care.
Dr. Prashant Vempati, Director of CNS Radiation Oncology and Director of Radiosurgery in Radiation Oncology at UH Seidman Cancer Center, and Dr. Tiffany Hodges, Neurosurgeon, Peter D. Cristal Endowed Chair in Neurosurgery and Surgical Director of the Brain Tumor Center, UH Seidman Cancer Center offered a joint statement: “We are very excited to bring this incredibly innovative cutting-edge technology to UH Seidman Cancer Center. Akesis is more than just a radiosurgery machine—it represents our deep commitment to patients and community. It’s a promise of healing, and of lives transformed through the power of precision, innovation, and compassion.”
About Akesis.Inc
Akesis, named after a Greek god of healing, is developing innovative SRS and SBRT platforms that incorporate patented rotational Gamma and advanced LINAC technologies, with real-time, in-plane imaging guidance. Akesis is creating the next evolution in Radiation Medicine by enhancing the accessibility, efficiency and efficacy of radiation medicine.
https://akesis.com/
About Galaxy RTi
Galaxy RTi is a rotating gamma system that combines the proven efficacy of gamma radiation with state-of-the-art rotational technology to optimize treatment planning and delivery. The system’s dynamic, rotational delivery provides more coverage and the ability to shape the dose distribution as opposed to traditional, fixed sector-based delivery. It is the only gamma SRS system with in-plane CBCT setup and in-plane in-treatment skull tracking capability.
https://akesis.com/akesis-galaxy-rti/
About University Hospitals Seidman Cancer Center/Cleveland, Ohio
UH Seidman Cancer Center is the only freestanding cancer hospital in Northeast Ohio, where all clinicians and staff are dedicated to the prevention, diagnosis and treatment of cancer while researching new and innovative treatment options through clinical trials. Nationally ranked cancer care is also available to patients through the 12-county region at 18 community-based locations. Our UH Seidman specialists make up 14 cancer-specific teams focused on determining integrated care plans tailored to patient’s needs. UH Seidman Cancer Center is part of the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center at Case Western Reserve University, one of 57 comprehensive cancer centers in the country. Patients have access to advanced treatment options, ranging from a pioneering stem cell transplant program founded more than 45 years ago and a wide range of immunotherapy to the first and only proton therapy center in northern Ohio for adults and children. Go to UHhospitals.org/Cancer for more information.
About University Hospitals / Cleveland, Ohio
Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 21 hospitals (including five joint ventures), more than 50 health centers and outpatient facilities, and over 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship quaternary care, academic medical center, University Hospitals Cleveland Medical Center, is affiliated with Case Western Reserve University School of Medicine, Northeast Ohio Medical University, Oxford University, the Technion Israel Institute of Technology and . National Taiwan University College of Medicine. The main campus also includes the UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, with more than 3,000 active clinical trials and research studies underway. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to 19 Clinical Care Delivery and Research Institutes. UH is one of the largest employers in Northeast Ohio with more than 30,000 employees. Follow UH on LinkedIn, Facebook and Twitter. For more information, visit UHhospitals.org.
END